FGF21 and steatosis: That is, chronically treated ob/ob mice exhibit reduced circulating and liver fatty acids and increased circulating FGF21 and adiponectin as well as a significant suppression of the de novo hepatic lipogenic enzymatic cascade, providing an explanation for the reversal of steatosis.